日本、美国和英国药剂师新扩展职能的比较

A. Kawahara
{"title":"日本、美国和英国药剂师新扩展职能的比较","authors":"A. Kawahara","doi":"10.22377/ijgp.v15i2.3090","DOIUrl":null,"url":null,"abstract":"Introduction: Pharmacists’ role had been changed to be focused more as an expert on medication therapy such as collaborative drug therapy management in the US and supplemental prescriber and independent prescriber in the UK. The Ministry of Health, Labor and Welfare (MHLW) in Japan published a notice, “Enhancing the team approach in health care system by the cooperation of heath care provider,” that stated outlines about pharmacists’ role as an expert on medication therapy. In this manuscript, we compare the regulations among the US, the UK, and Japan and discuss how Japanese pharmacists should conduct their expected role. Materials and Methods: Databases used to identify laws and regulations on the new pharmacists’ role in the three countries are as follows; WestLaw® for the US, the legistration.gov.uk for the UK, and “Database services of acts and regulations on health, labor and welfare” at the MHLW website for Japan. Results: Comparison on the laws and regulations shows each regulatory authority established each way to regulate the new pharmacists’ role even though the role in each country is quite similar. In Japan, pharmacists have limited prescription rights by sharing the rights with the physician under the protocol within the Japanese team approach model, but the regulations are minimum. Discussion and Conclusions: The laws and regulations for the new pharmacists’ role are broken away from sameness or identify among the three countries. In Japan, an individual pharmacist must build up strong credibility with the team members and the patient and must show his/her capability to them when playing the new pharmacists’ role.","PeriodicalId":14055,"journal":{"name":"International Journal of Green Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of new expanded functions of pharmacists among Japan, the US, and the UK\",\"authors\":\"A. Kawahara\",\"doi\":\"10.22377/ijgp.v15i2.3090\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Pharmacists’ role had been changed to be focused more as an expert on medication therapy such as collaborative drug therapy management in the US and supplemental prescriber and independent prescriber in the UK. The Ministry of Health, Labor and Welfare (MHLW) in Japan published a notice, “Enhancing the team approach in health care system by the cooperation of heath care provider,” that stated outlines about pharmacists’ role as an expert on medication therapy. In this manuscript, we compare the regulations among the US, the UK, and Japan and discuss how Japanese pharmacists should conduct their expected role. Materials and Methods: Databases used to identify laws and regulations on the new pharmacists’ role in the three countries are as follows; WestLaw® for the US, the legistration.gov.uk for the UK, and “Database services of acts and regulations on health, labor and welfare” at the MHLW website for Japan. Results: Comparison on the laws and regulations shows each regulatory authority established each way to regulate the new pharmacists’ role even though the role in each country is quite similar. In Japan, pharmacists have limited prescription rights by sharing the rights with the physician under the protocol within the Japanese team approach model, but the regulations are minimum. Discussion and Conclusions: The laws and regulations for the new pharmacists’ role are broken away from sameness or identify among the three countries. In Japan, an individual pharmacist must build up strong credibility with the team members and the patient and must show his/her capability to them when playing the new pharmacists’ role.\",\"PeriodicalId\":14055,\"journal\":{\"name\":\"International Journal of Green Pharmacy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Green Pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22377/ijgp.v15i2.3090\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Green Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22377/ijgp.v15i2.3090","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

导言:药剂师的角色已经转变为更专注于药物治疗的专家,如美国的协同药物治疗管理和英国的补充处方者和独立处方者。日本厚生劳动省(MHLW)发布了一份通知,“通过医疗保健提供者的合作,加强医疗保健系统的团队方法”,其中概述了药剂师作为药物治疗专家的作用。在这份手稿中,我们比较了美国,英国和日本之间的法规,并讨论了日本药剂师应该如何进行预期的作用。材料与方法:用于识别三国新药师角色法律法规的数据库如下;美国的WestLaw®,英国的legislative .gov. UK,日本的MHLW网站上的“卫生、劳动和福利法律法规数据库服务”。结果:通过对法律法规的比较,可以发现各国监管部门对新药师角色的监管方式各不相同,尽管各国的角色相似。在日本,根据日本团队模式的协议,药剂师与医生分享处方权利,但规定很少。讨论与结论:三国关于新药师角色的法律法规存在着不一致或趋同的现象。在日本,药剂师个人必须在团队成员和患者中建立强大的信誉,并且在扮演新的药剂师角色时必须向他们展示自己的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparison of new expanded functions of pharmacists among Japan, the US, and the UK
Introduction: Pharmacists’ role had been changed to be focused more as an expert on medication therapy such as collaborative drug therapy management in the US and supplemental prescriber and independent prescriber in the UK. The Ministry of Health, Labor and Welfare (MHLW) in Japan published a notice, “Enhancing the team approach in health care system by the cooperation of heath care provider,” that stated outlines about pharmacists’ role as an expert on medication therapy. In this manuscript, we compare the regulations among the US, the UK, and Japan and discuss how Japanese pharmacists should conduct their expected role. Materials and Methods: Databases used to identify laws and regulations on the new pharmacists’ role in the three countries are as follows; WestLaw® for the US, the legistration.gov.uk for the UK, and “Database services of acts and regulations on health, labor and welfare” at the MHLW website for Japan. Results: Comparison on the laws and regulations shows each regulatory authority established each way to regulate the new pharmacists’ role even though the role in each country is quite similar. In Japan, pharmacists have limited prescription rights by sharing the rights with the physician under the protocol within the Japanese team approach model, but the regulations are minimum. Discussion and Conclusions: The laws and regulations for the new pharmacists’ role are broken away from sameness or identify among the three countries. In Japan, an individual pharmacist must build up strong credibility with the team members and the patient and must show his/her capability to them when playing the new pharmacists’ role.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信